Replies to post #371140 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Additional work tied to starting, in 2022, a planned Phase 3 study of Brilacidin in Oral Mucositis is also in progress."

Don't know why you left this out...same May PR, previous sentence:
"Development work related to the formulation and manufacture of Brilacidin in capsule form is underway to support our Phase 2 trial in Ulcerative Colitis planned to commence this year."